tiprankstipranks

New Portfolio - New Portfolio

James Robinson

New Portfolio
Individual Investor
Ranked #311,478 out of 769,603 TipRanks' Investors
Success Rate
54%
162 out of 300
profitable transactions
Average Return
5.66%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.06%
6-Month Return▲ 1.96%
12-Month Return▲ 23.12%
YTD Return▲ 9.05%
Total Return▼ 14.91%

Best Trade

Opened at
Closed at-
Gain▲ 397.08%

Bio

This is my investment portfolio, I am a long term investor, although, their are times i make swing trades. I started investing 5 yrs ago.

Performance

37.60%0-37.60%
▼ 12.40%
▼ 4.03%
▼ 9.33%
Apr 2024
▲ 11.46%
▲ 5.06%
▲ 4.96%
May 2024
▼ 2.25%
▲ 3.53%
▲ 6.67%
Jun 2024
▲ 25.72%
▲ 1.21%
▲ 4.85%
Jul 2024
▼ 4.22%
▲ 2.34%
▼ 5.35%
Aug 2024
▲ 7.82%
▲ 2.10%
▼ 5.58%
Sep 2024
▲ 5.70%
▼ 0.89%
▼ 2.36%
Oct 2024
▲ 37.60%
▲ 4.40%
▲ 4.00%
Nov 2024
TipRanks AverageS&P 500Investor Portfolio
▼ 12.40%▼ 4.03%▼ 9.33%
▲ 11.46%▲ 5.06%▲ 4.96%
▼ 2.25%▲ 3.53%▲ 6.67%
▲ 25.72%▲ 1.21%▲ 4.85%
▼ 4.22%▲ 2.34%▼ 5.35%
▲ 7.82%▲ 2.10%▼ 5.58%
▲ 5.70%▼ 0.89%▼ 2.36%
▲ 37.60%▲ 4.40%▲ 4.00%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Erasca
▲ 18.44%
2
Close
Sep 18, 2024
Fulcrum Therapeutics
▼ 56.34%
4
Close
Sep 18, 2024
Gladstone Capital
▲ 0.69%
2
Close
Sep 18, 2024
Immunic
▲ 26.58%
3
Close
Sep 18, 2024
Palantir Technologies
▲ 17.93%
2
Close
Sep 18, 2024
Robinhood Markets
4.05%
▲ 30.56%
6
Sell
Sep 02, 2024
Annexon Biosciences
▼ 1.54%
5
Close
Sep 02, 2024
Global X NASDAQ 100 Covered Call ETF
▲ 7.26%
2
Close
Sep 02, 2024
VICI Properties
▲ 12.25%
3
Close
Sep 02, 2024
Citius Pharmaceuticals
▼ 30.49%
2
Close
Sep 02, 2024
Tilray
▲ 3.43%
6
Close
Aug 26, 2024
SNDL
1.09%
▼ 11.25%
4
Buy
Aug 26, 2024
Microsoft
4.6%
▲ 19.23%
4
Buy
Aug 26, 2024
Meta Platforms
3.09%
▲ 76.93%
4
Buy
Aug 26, 2024
Alphabet Class A
1.82%
▲ 29.59%
4
Buy
Aug 26, 2024
Nvidia
7.93%
▲ 223.26%
4
Buy
Aug 26, 2024
Advanced Micro Devices
3.06%
▲ 15.96%
4
Buy
Aug 26, 2024
Oracle
2.12%
▲ 70.01%
3
Buy
Aug 26, 2024
Adverum Biotechnologies
8%
▼ 31.32%
5
Buy
Aug 26, 2024
Crispr Therapeutics AG
6.34%
▼ 17.08%
3
Buy
Aug 26, 2024